Clinical Trial Update: Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated bismuth subsalicylate for prevention of travelers' diarrhea; the study was terminated and its results have been posted on ClinicalTria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-resistant Infection
• Travelers Diarrhea

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Diarrhea Travelers, Antibiotic Resistant Infection | Phase 3 | Status: TERMINATED | Results posted: 2025-03-12